ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RTWG Rtw Biotech Opportunities Ltd

105.00
1.00 (0.96%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rtw Biotech Opportunities Ltd LSE:RTWG London Ordinary Share GG00BKTRRM22 ORD NPV (GBP)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.96% 105.00 103.00 107.00 106.00 103.00 103.00 171,946 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 2.17M -5.29M -0.0251 -42.23 223.27M

RTW Venture Fund Limited Notice of AGM (2247B)

01/06/2023 7:00am

UK Regulatory


Rtw Biotech Opportunities (LSE:RTWG)
Historical Stock Chart


From Apr 2023 to Apr 2024

Click Here for more Rtw Biotech Opportunities Charts.

TIDMRTW

RNS Number : 2247B

RTW Venture Fund Limited

01 June 2023

LEI: 549300Q7EXQQH6KF7Z84

   1 June   2023 

RTW Venture Fund Limited

Notice of Annual General Meeting

RTW Venture Fund Limited (the "Company") announces that its Annual General Meeting ("AGM") will be held at 1(st) Floor Royal Chambers, St Julian's Avenue St Peter Port, Guernsey on 21 June 2023 at 2pm BST. The Notice of AGM was dispatched to all shareholders on 31 May 2023.

A copy of the Notice of AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism The Notice of AGM may also be viewed on the Company's website at https://www.rtwfunds.com/venture-fund/ .

The Annual Report and Audited Financial Statements for the year ended 31 December 2022 (the "Annual Report") is also available on the Company's website https://www.rtwfunds.com/venture-fund/ at and on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

You will not have received a hard copy proxy form for the AGM in the post. You can instead submit your proxy vote electronically by accessing the shareholder portal at www.signalshares.com , logging in and selecting the 'Vote Online Now' link. Full details of how to vote are set out in the Notes to the Notice of Meeting. Please submit your proxy vote so as to reach the Company's registrar as soon as possible and in any event no later than 2pm BST on 19 June 2023 or, if you are a CREST member, by using the service provided by Euroclear. The completion of the form of proxy will not preclude a member from attending and voting in person at the meeting if it is so allowed.

If any shareholder has questions related to the business of the AGM, please submit your queries to RTWVentureFund@rtwfunds.com by 2pm BST on 19 June 2023. We will endeavour to answer every shareholder question and responses will be posted on the Company's website after the AGM.

For Further Information

 
 RTW Investments, LP                         +44 (0)20 7959 6361 
 Woody Stileman, Managing Director 
  Krisha McCune, Director, Client Service 
 
 Buchanan Communications                     +44 (0)20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund Limited invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOASDDFIFEDSEDI

(END) Dow Jones Newswires

June 01, 2023 02:00 ET (06:00 GMT)

1 Year Rtw Biotech Opportunities Chart

1 Year Rtw Biotech Opportunities Chart

1 Month Rtw Biotech Opportunities Chart

1 Month Rtw Biotech Opportunities Chart

Your Recent History

Delayed Upgrade Clock